Eli Lilly and Co (LLY)

LLY (NYSE:Drugs)
$63.10
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | LLY Avg Daily Volume: 3,877,700
Last Update: 10/20/14 - 4:01 PM EDT
Volume: 0
YTD Performance: 23.73%
Open: $0.00
Previous Close: $63.10
52 Week Range: $48.88 - $67.14
Oustanding Shares: 1,117,308,330
Market Cap: 69,921,155,291
6-Month Chart
TheStreet Ratings Grade for LLY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 5 5
Moderate Buy 0 0 0 0
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.29 2.29 2.38 2.38
Latest Dividend: 0.49
Latest Dividend Yield: 3.17%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 19.87
Price Earnings Comparisons:
LLY Sector Avg. S&P 500
19.87 19.90 27.19
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.58% 27.32% 63.43%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.30 0.00 0.00
Net Income 14.60 -0.08 -0.03
EPS 18.00 -0.05 -0.02
Earnings for LLY:
EBITDA 6.99B
Revenue 23.11B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $0.67 $0.71 $2.77 $3.14
Number of Analysts 8 7 12 12
High Estimate $0.69 $0.74 $2.80 $3.39
Low Estimate $0.63 $0.67 $2.74 $2.97
Prior Year $1.11 $0.74 $4.15 $2.77
Growth Rate (Year over Year) -39.98% -3.47% -33.21% 13.20%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Oct 9, 2014 | 4:08 PM EDT

Stop picking on PepsiCo, Allergan and Apple.

bullishEli Lilly rated new Buy at Deutsche

Aug 27, 2014 | 7:17 AM EDT

Coverage of LLY was started with a Buy rating, Deutsche Bank said. $71 price target. Company is poised to return to growth in the coming years. 

bearishEli Lilly downgraded at Citi

Jul 31, 2014 | 8:08 AM EDT

LLY was downgraded to Neutral, Citigroup said. Alimta risks are under-appreciated in the market. 

By

Jim Cramer

 | Jul 28, 2014 | 6:45 AM EDT

If you insist on playing it, recognize the 50/50 nature of the scenario.

By

Scott Redler

 | Jul 23, 2014 | 7:12 PM EDT

Marathon Oil and Morgan Stanley have traded through our entry prices.

By

Scott Redler

 | Jul 14, 2014 | 7:52 PM EDT

Molson Coors doesn't offer a good entry point, but CME Group opens the door for shorts.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Gary Morrow

 | Jun 20, 2014 | 12:24 PM EDT

The shares are in full breakout mode today.

updateLLY Investor Mtg.

May 6, 2014 | 6:50 AM EDT

LLY - Eli Lilly Annual Shareholder Meeting 

bearishEli Lilly downgraded at Leerink

Apr 23, 2014 | 7:51 AM EDT

LLY was downgraded from Buy to Neutral, Leerink Swann said. $61 price target. Company lacks near-term catalysts and made an expensive acquisition of Novartis' animal health business.

At the bottom last Wednesday I doubt that many people would have predicted the headline ab...
FB has earnings due out on 10-28-2014, after the market closes. I will write a full earni...
Solid opening day to trading week for a change as indices across the board as even the DJI...
Apple reports after the close today. St expecting Q4 rev of $39.877 billion, up 6.4%. EPS ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.